<DOC>
	<DOCNO>NCT00013923</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness nutritional supplement develop improve brain function patient Alzheimer 's disease .</brief_summary>
	<brief_title>Effectiveness A Nutritional Brain Metabolic Enhancer Alzheimer Disease</brief_title>
	<detailed_description>The ability brain use major fuel , sugar glucose , reduce Alzheimer 's disease . A nutritional supplement develop improve function Alzheimer brain increase ability use sugar effectively . The ingredient supplement natural product , find normal American diet . Results encourage open trial patient know take active medicine . Patients invited participate placebo-controlled trial last 3 month , follow 3-month open label trial patient receive active preparation . This double-blind , placebo-controlled , parallel-group , 3 month trial follow 3-month open-label period , nutritional supplement design improve brain metabolism function patient Alzheimer 's disease ( AD ) . The design nutritional supplement base replicated observation abnormality mitochondria AD . The constituent nutritional supplement component normal American diet , classify FDA GRAS ( Generally Regarded As Safe ) . Results supplement favorable preliminary , open trial ( eg mean improvement MMSE score +4.9 , range +3 +8 , n = 7 , P &lt; 0.0004 ) . During placebo-controlled portion trial , half participant receive active preparation half sugar pill . During first phase , neither patient test know take active medicine take placebo . The active supplement placebo take 1 tablespoon twice day , meal . If desire , supplement placebo stir , wash , water , coffee tea without milk sugar , soft drink TAB . Patient visit Burke Medical Research Institute month , screen baseline visit . The supplement take one tablespoon fluid , meal . Since sugar citrate expect interfere action supplement , food drink contain sugar citrate diet drink contain citrate avoid 1 1/2 hour 1 1/2 hour take supplement . No significant adverse event associate supplement . However , standard precaution patient safety take , include medical examination clinical laboratory test screen completion double-blind open-label phase .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Inclusion criterion include : A documented diagnosis Alzheimer 's disease ; MMSE score 10 26 inclusive ; A reliable caregiver ensure compliance . Exclusion criterion include : diabetes , unstable medical illness , myocardial infarction cancer diagnose within previous 12 month , treatment systemic steroid . Patients treated depression psychiatric symptomatology eligible , symptom control stable dose medication</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2003</verification_date>
	<keyword>Nutritional Supplement</keyword>
</DOC>